TGF-β1 reduction in AD patients has been recorded in another study, De Servi et al. (2002) verifying the findings of Huang et al. However, Kim and Kim (2012) recorded AD patients as possessing higher serum VEGF, while angiogenin (protein that stimulates angiogenesis) is reduced. This evidence concerns the gene VEGFA and Alzheimer disease.